Journal of Current Ophthalmology最新文献

{"title":"Posterior Microphthalmos Pigmentary Retinopathy Syndrome with Angle-Closure Glaucoma: A Case Report.","authors":"Hela Sassi,&nbsp;Khaled Ammar,&nbsp;Meriem Ouederni,&nbsp;Monia Cheour","doi":"10.4103/joco.joco_145_22","DOIUrl":"https://doi.org/10.4103/joco.joco_145_22","url":null,"abstract":"<p><strong>Purpose: </strong>To describe a particular form of posterior microphthalmos pigmentary retinopathy syndrome (PMPRS) with an atypical clinical presentation of pigment retinal dystrophy and an association to an inconstant complication which is angle-closure glaucoma (ACG).</p><p><strong>Methods: </strong>A 40-year-old male patient with ACG on maximal topical treatment was referred to our department for uncontrolled intraocular pressure. Best-corrected visual acuity was 2/10 in the right eye and light perception in the left eye. Intraocular pressure was 36 mmHg bilaterally. He had 360° peripheral anterior synechiae on gonioscopy. Fundus examination revealed total cupping with pale retinal lesions in both eyes and a few pigment deposits in the midperiphery of the right eye. Multimodal imaging was done.</p><p><strong>Results: </strong>Fundus autofluorescence revealed patchy areas of hypoautofluorescence. Optical coherence tomography (OCT) showed bilateral foveoschisis and macular folds. Anterior segment OCT showed a circumferential iridocorneal angle closure. Axial length measured with ultrasound biomicroscopy was 18.4 mm in the right eye and 18.1 in the left eye. Electroretinogram revealed attenuated scotopic responses. The patient was diagnosed with nanophthalmos-retinitis pigmentosa (RP)-foveoschisis syndrome complicated with ACG. A combined surgery with phacoemulsification - anterior vitrectomy - intraocular lens implantation and trabeculectomy was performed in both eyes with a satisfactory outcome.</p><p><strong>Conclusions: </strong>In its typical forms, PMPR syndrome is an association of nanophthalmos - RP - foveoschisis and optic nerve head (ONH) drusen. Incomplete phenotypes may lack ONH drusen or foveoschisis. Patients with PMPRS have to be screened for iridocorneal angle synechia and ACG.</p>","PeriodicalId":15423,"journal":{"name":"Journal of Current Ophthalmology","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/92/90/JCO-34-474.PMC10170979.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10662701","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Bilateral Acute Iris Transillumination without Prior Systemic Antibiotics.","authors":"Mohamed F Oraby,&nbsp;Salah Aldin Alrashidi,&nbsp;Sherein Mahmoud Hagras","doi":"10.4103/joco.joco_93_22","DOIUrl":"https://doi.org/10.4103/joco.joco_93_22","url":null,"abstract":"<p><strong>Purpose: </strong>To describe a case of bilateral acute iris transillumination (BAIT) with no history of systemic infections or antibiotics intake before the attack.</p><p><strong>Methods: </strong>This study included the review of the clinical record of the patient.</p><p><strong>Results: </strong>A 29-year-old male was referred to the glaucoma clinic with presumed bilateral acute iridocyclitis with refractory glaucoma. Ophthalmic examination revealed bilateral pigment dispersion, marked iris transillumination, dense pigment deposition in the iridocorneal angle, and high intraocular pressure. The patient was diagnosed with BAIT and was followed for 5 months.</p><p><strong>Conclusion: </strong>The diagnosis of BAIT can be elicited even without a prior history of systemic infection or antibiotics intake.</p>","PeriodicalId":15423,"journal":{"name":"Journal of Current Ophthalmology","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/91/10/JCO-34-469.PMC10170978.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9822301","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Comparison of the Sedative, Hemodynamic, and Anesthetic Effect of Dexmedetomidine, Ketamine, and Etomidate on Cataract Surgery by Phacoemulsification Method: A Randomized Clinical Trial.","authors":"Bardia Moghisseh,&nbsp;Hesameddin Modir,&nbsp;Esmail Moshiri,&nbsp;Zahra Motaghinia,&nbsp;Mohammadreza Bozorgmanesh","doi":"10.4103/joco.joco_158_22","DOIUrl":"https://doi.org/10.4103/joco.joco_158_22","url":null,"abstract":"<p><strong>Purpose: </strong>To compare dexmedetomidine, ketamine, and etomidate in the induction of sedation and hemodynamic changes in patients undergoing cataract surgery by phacoemulsification method.</p><p><strong>Methods: </strong>This was a double-blind clinical trial study carried out on 128 patients. Using the block randomization method, the patients were divided into four equal groups (dexmedetomidine, ketamine, etomidate, and control). Mean arterial pressure, heart rate, and arterial oxygen saturation, Ramsay Sedation Score were recorded every 5 min intraoperatively, in recovery, and 1, 2, 4, and 6 h postoperatively. Moreover, the Aldrete score was measured in recovery time for discharge from the recovery room.</p><p><strong>Results: </strong>The mean age of participants was found to be 63.16 ± 6.07 years, and there was no statistically significant difference between the groups in terms of age, sex, and body mass index, SpO_2, and heart rate (<i>P</i> > 0.05). From 15 min after the start of surgery to 6 h postoperatively, the mean arterial pressure in the dexmedetomidine group was significantly lower than that in the other three groups, including ketamine, etomidate, and control (<i>P</i> < 0.05). The mean sedation score (Ramsay) during recovery and 1 h postoperatively was higher in the dexmedetomidine group compared with that in the control group, whereas the recovery time in the dexmedetomidine group was higher than that in the other groups (<i>P</i> < 0.001). In addition, the amount of propofol consumption in the two groups of dexmedetomidine and ketamine was significantly less than that in the etomidate and control groups (<i>P</i> < 0.001).</p><p><strong>Conclusions: </strong>According to the results, dexmedetomidine caused better hemodynamic changes with more reduction in blood pressure and heart rate, and patients in the dexmedetomidine group did not require any specific medical treatment. Moreover, higher patient satisfaction and longer recovery duration were observed in the dexmedetomidine group than in the other study groups. As such, it is suggested that dexmedetomidine be used as an adjuvant in cataract surgery for more sedation, analgesia, and optimal intraoperative conditions.</p>","PeriodicalId":15423,"journal":{"name":"Journal of Current Ophthalmology","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/91/47/JCO-34-414.PMC10170987.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9469876","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Management of Malignant Glaucoma.","authors":"Reza Sadeghi,&nbsp;Ali Momeni,&nbsp;Ghasem Fakhraie,&nbsp;Yadollah Eslami,&nbsp;Reza Zarei,&nbsp;Zakieh Vahedian,&nbsp;Mona Safizadeh,&nbsp;Seyed Mehdi Tabatabaei","doi":"10.4103/joco.joco_147_22","DOIUrl":"https://doi.org/10.4103/joco.joco_147_22","url":null,"abstract":"<p><strong>Purpose: </strong>To compare the outcomes of various invasive and noninvasive approaches to the treatment of malignant glaucoma.</p><p><strong>Methods: </strong>Glaucoma-related keywords were looked up in PubMed and Google Scholar, and related articles up to 2022 were used to put together this review article.</p><p><strong>Results: </strong>Numerous surgical methods and techniques have been introduced in the past few years. This review outlined current knowledge regarding the nonsurgical and surgical management of malignant glaucoma. In this regard, we first briefly outlined the clinical presentation, pathophysiology, and diagnosis of this disorder. Then, the current evidence on the management of malignant glaucoma was reviewed. Finally, we discuss the need for treatment of the other eye and the factors that might affect the outcome of surgical intervention.</p><p><strong>Conclusions: </strong>Fluid misdirection syndrome, or malignant glaucoma, is a severe disorder that can occur spontaneously due to surgical intervention. The pathophysiology of malignant glaucoma is complicated, and numerous theories exist about the underlying mechanisms that may contribute to the disease. Malignant glaucoma can be treated conservatively using medications, laser therapy, or surgery. Laser treatments and medical treatments have been adequate for the treatment of glaucoma, but the effects have generally been short-lived, and surgical treatment has proved to be the most effective. There have been a variety of surgical methods and techniques introduced. Still, none have been studied in a large proportion of patients as a control case to compare effectiveness, outcomes, and recurrence. Pars plana vitrectomy with irido-zonulo-capsulectomy still seems to have the best results.</p>","PeriodicalId":15423,"journal":{"name":"Journal of Current Ophthalmology","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/65/8a/JCO-34-389.PMC10170992.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9822299","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Impact of Coronavirus Disease 2019 Pandemic on the Epidemiology of Intravitreal Injections.","authors":"Masoud Mirghorbani,&nbsp;Hamid Riazi-Esfahani,&nbsp;Fatemeh Bazvand,&nbsp;Mohammadreza Mehrabi Bahar,&nbsp;Mehdi Yaseri,&nbsp;Mohammad Zarei","doi":"10.4103/joco.joco_253_22","DOIUrl":"https://doi.org/10.4103/joco.joco_253_22","url":null,"abstract":"<p><strong>Purpose: </strong>To evaluate the epidemiologic pattern of intravitreal injections (IVIs) during Coronavirus Disease 2019 (COVID-19) pandemic.</p><p><strong>Methods: </strong>The records of patients receiving IVIs in two 12-month periods immediately before and after the beginning of the COVID-19 epidemic were included. Age, province of residency, indication, number of injections, and number of operating room (OR) visits were analyzed.</p><p><strong>Results: </strong>Compared to pre-COVID period, a 37.6% decrease in the number of patients receiving IVI in COVID period was seen (10518 vs. 6569). There was a parallel decrease in the number of OR visits (25590 vs. 15010: 41.4%) and injections (34508 vs. 19879: 42.4%). Regarding IVI indication, age-related macular degeneration (AMD) showed the highest decrease in IVI rate (46.3%) which was significantly higher than decrease in other indications (<i>P</i> < 0.001). Retinopathy of prematurity (ROP) patients showed no change after epidemic. Mean overall age in AMD group was the highest (67.7 ± 13.2 years) compared to other indication groups (excluding ROP) (<i>P</i> < 0.001); while the mean age of the other indications was not significantly different from each other (excluding ROP).</p><p><strong>Conclusions: </strong>COVID pandemic decreased the number of IVIs significantly. While previous studies suggested that the AMD patients had the highest risk of visual loss due to failure to receive IVIs in a timely manner, this very same group showed the highest decrease in the IVI number after pandemic. The health systems should devise strategies to protect this most vulnerable group of patients in future similar crises.</p>","PeriodicalId":15423,"journal":{"name":"Journal of Current Ophthalmology","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/7a/8c/JCO-34-442.PMC10170993.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9523136","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Is Type 2 Macular Telangiectasia a Bilateral and Symmetrical Disease Entity?","authors":"Ramesh Venkatesh,&nbsp;Harshita Nahata,&nbsp;Nikitha Gurram Reddy,&nbsp;Pranjal Mishra,&nbsp;Rubble Mangla,&nbsp;Naresh Kumar Yadav,&nbsp;Jay Chhablani","doi":"10.4103/joco.joco_68_22","DOIUrl":"https://doi.org/10.4103/joco.joco_68_22","url":null,"abstract":"<p><strong>Purpose: </strong>To study the inter-eye asymmetry in cases diagnosed with type 2 macular telangiectasia (MacTel).</p><p><strong>Methods: </strong>Herein, type 2 MacTel cases were staged as per Gass and Blodi classification with multiple imaging techniques. Based on disease stage symmetry, two groups identified. Group 1: Symmetrical stage and Group 2: Asymmetrical stage MacTel disease. Prevalence, demography, and clinical features of MacTel cases showing inter-eye asymmetry were analyzed.</p><p><strong>Results: </strong>Two hundred and eighty eyes of 140 patients diagnosed clinically with type 2 MacTel (84-Group 1 and 56-Group 2) were evaluated. Eighty-nine (64%) were female, and the median age of the entire cohort was 62.5 years (inter-quartile range: 57.0-68.75). MacTel disease with asymmetric stage was seen in 56 (40%) of the 140 patients. At presentation, a two-stage difference was noted in 46% (<i>n</i> = 26) of the patients with asymmetrical MacTel disease. A 10% conversion from symmetrical to asymmetrical disease stage was noted at the final visit. Of the 280 eyes evaluated for type 2 MacTel disease, 12 (4%) eyes showed no findings suggestive of MacTel on clinical examination and fluorescein angiography, optical coherence tomography (OCT), and OCT angiography when available and were labeled as unilateral type 2 MacTel disease.</p><p><strong>Conclusions: </strong>Type 2 MacTel can show inter-eye disease stage asymmetry. Unilateral type 2 MacTel disease is a distinct stage in MacTel which would need further evaluation and consideration while staging.</p>","PeriodicalId":15423,"journal":{"name":"Journal of Current Ophthalmology","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/b5/7f/JCO-34-428.PMC10170975.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9469875","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Association of Risk Factors among Nasal and Orbital Mucormycosis in Coronavirus Disease 2019 Infection: A Cross-Sectional Study.","authors":"Ramasamy Vidhyadevi,&nbsp;S Saudhamini,&nbsp;Sundaram Padmanaban,&nbsp;Devisundaram Sundar,&nbsp;Suvetha Kannappan,&nbsp;Gopalsamy Suryaprabha","doi":"10.4103/joco.joco_78_22","DOIUrl":"https://doi.org/10.4103/joco.joco_78_22","url":null,"abstract":"<p><strong>Purpose: </strong>To study the risk factors of mucormycosis and analyze their association among nasal and orbital mucormycosis in Coronavirus disease 2019 (COVID-19) infection.</p><p><strong>Methods: </strong>All patients diagnosed of rhino-orbito-cerebral mucormycosis (ROCM) with previous COVID-19 infection were included in the study. The details such as age, sex, presence of co-morbidities, and serum ferritin levels were collected. ROCM patients were classified into two groups, nasal mucormycosis (stage 1 and 2 of ROCM) and orbital mucormycosis (stage 3 and 4 of ROCM), and data were collected. Duration of COVID-19 symptoms, the time interval between COVID-19 infection and onset of ROCM symptoms, computed tomography severity score (CTSS) and usage of steroids were collected accordingly. The collected data were compared between nasal group and orbital group.</p><p><strong>Results: </strong>Among 52 patients, 15 patients had nasal and 37 patients had orbital mucormycosis. Forty-one patients were more than 40 years, 43 patients were males. Seven out of ten risk factors were found to be significant on comparing nasal and orbital group. Patients of age more than 40 years (<i>P</i> = 0.034), elderly diabetics (<i>P</i> = 0.014), poor control of diabetes (<i>P</i> = 0.003), high serum ferritin levels (<i>P</i> = 0.043), duration between COVID-19 and mucormycosis of more than 20 days (<i>P</i> = 0.038), CTSS of more than 9/25 (<i>P</i> = 0.020), and steroid usage during COVID-19 infection (<i>P</i> = 0.034) are prone to develop orbital mucormycosis. On multivariate logistic regression analysis, these variables did not emerge as independent risk factors.</p><p><strong>Conclusions: </strong>Patients with severe COVID-19 infection along with other associated risk factors can be prone to develop severe forms of mucormycosis. We did not find them to be statistically significant on multivariate analysis. In the future, large scale studies are needed to know their significance.</p>","PeriodicalId":15423,"journal":{"name":"Journal of Current Ophthalmology","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/98/97/JCO-34-460.PMC10170986.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9472964","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Medial Rectus Plication in the Management of Dissociated Horizontal Deviation: Case Report and Literature Review.","authors":"Mohammad Yaser Kiarudi,&nbsp;Bahar Tafaghodi,&nbsp;Aliakbar Sabermoghadm,&nbsp;Acieh Es'haghi,&nbsp;Seyed Hosein Ghavami Shahri","doi":"10.4103/joco.joco_6_22","DOIUrl":"https://doi.org/10.4103/joco.joco_6_22","url":null,"abstract":"<p><strong>Purpose: </strong>To report a case of medial rectus plication for the management of dissociated horizontal deviation (DHD).</p><p><strong>Methods: </strong>We introduce medial rectus plication for improving the control of exoshift of DHD.</p><p><strong>Results: </strong>A 20-year-old woman with a chief complaint of left eye outward deviation since childhood was referred to the strabismus clinic. The diagnosis of DHD was made according to the detection of asymmetric slow abduction of the left eye (50 prism diopter) during visual inattention or cover testing. The left lateral rectus (LR) was recessed 8 mm with a posterior fixation suture (PFS). In the early postoperative period, the control of DHD improved; however, after 6 months, the patient and her parents complained of frequent observation of the exoshift of the left eye (30 prism diopter). For better control of DHD, medial rectus plication (5 mm) of the left eye was considered the second operation. After 12 months of follow-up, the control of deviation improved, and there was no manifest deviation.</p><p><strong>Conclusions: </strong>The literature's recommended procedure for unilateral DHD without a duction deficit is to perform a unilateral LR muscle recession. Some authors have proposed adding PFS to augment the effect of LR recessions. Although recurrence may occur, medial rectus plication can be considered one of the reversible options and can be used in recurrences of DHD after the first surgical procedure.</p>","PeriodicalId":15423,"journal":{"name":"Journal of Current Ophthalmology","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/c5/3e/JCO-34-483.PMC10170982.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9469874","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Risk Factors for Uncorrected Refractive Error: Persian Cohort Eye Study - Rafsanjan Center.","authors":"Mohammadreza Soleimani,&nbsp;Bahar Saberzadeh-Ardestani,&nbsp;Hamid Hakimi,&nbsp;Akbar Fotouhi,&nbsp;Fateme Alipour,&nbsp;Fatemeh Jafari,&nbsp;Alireza Lashay,&nbsp;Hassan Hashemi","doi":"10.4103/joco.joco_160_22","DOIUrl":"https://doi.org/10.4103/joco.joco_160_22","url":null,"abstract":"<p><strong>Purpose: </strong>To determine the prevalence of visually significant uncorrected refractive error (URE) in Rafsanjan and investigate the related factors. URE is the leading cause of visual impairment (VI) which causes the second-highest number of years lived with disability. The URE is a preventable health problem.</p><p><strong>Methods: </strong>In this cross-sectional study participants from Rafsanjan who were 35-70 years were enrolled between 2014 and 2020. Demographic and clinical characteristics data were gathered, and eye examination was performed. Visually significant URE was defined as present if habitual visual acuity was (HVA; visual acuity with present optical correction) >0.3 logMAR in the best eye and the visual acuity of that eye showed >0.2 logMAR improvement after the best correction. Logistic regression was used to determine the association between predicting variables (age, sex, wealth, education, employment, diabetes, cataract, and refractive error characteristics) and outcome (URE).</p><p><strong>Results: </strong>Among the 6991 participants of Rafsanjan subcohort of the Persian Eye Cohort, 311 (4.4%) had a visually significant URE. Diabetes was significantly more prevalent in the participants with visually significant URE, at 18.7% versus 13.1% in patients without significant URE (<i>P</i> = 0.004). In the final model, each year of increase in age was associated with 3% higher URE (95% confidence interval [CI]: 1.01-1.05). In comparison to low hyperopia, participants with low myopia had 5.17 times more odds of visually significant URE (95% CI: 3.38-7.93). However, antimetropia decreased the risk of visually significant URE (95% CI: 0.02-0.37).</p><p><strong>Conclusion: </strong>Policymakers should pay special attention to elderly patients with myopia to effectively reduce the prevalence of visually significant URE.</p>","PeriodicalId":15423,"journal":{"name":"Journal of Current Ophthalmology","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/07/a4/JCO-34-421.PMC10170991.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9469878","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Lacrimal Canalicular Bypass Surgery with Autologous Superficial Temporal Artery Graft.","authors":"Mansooreh Jamshidian-Tehrani,&nbsp;Mohsen Bahmani Kashkouli,&nbsp;Hossein Ghahvehchian,&nbsp;Mohammad Amini","doi":"10.4103/joco.joco_98_22","DOIUrl":"https://doi.org/10.4103/joco.joco_98_22","url":null,"abstract":"<p><strong>Purpose: </strong>To describe superficial temporal artery graft as a new autologous tissue to reconstruct the upper lacrimal drainage system.</p><p><strong>Methods: </strong>We explain the history of a 30-year-old female with upper lacrimal drainage system obstruction, in whom conjunctivodacryocystorhinostomy (CDCR) failed to resolve epiphora. A superficial temporal artery graft was harvested, intubated with Masterka tube, and implanted between the conjunctiva and nasal cavity. Masterka was replaced with a thicker dummy tube 12 weeks postoperatively. The adequacy of the graft was checked with irrigation tests in follow-up visits from 1 to 26 months after the procedure.</p><p><strong>Results: </strong>Superficial temporal artery autograft successfully eliminated epiphora of the patient in whom (CDCR) with Jones tube failed to make her symptom free.</p><p><strong>Conclusion: </strong>Superficial temporal artery autograft as an autogenous tissue with adequate characteristics can be considered in selective patients of upper lacrimal obstruction to reconstruct the lacrimal drainage system.</p>","PeriodicalId":15423,"journal":{"name":"Journal of Current Ophthalmology","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/5a/36/JCO-34-486.PMC10170988.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9523137","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}